NCT03317717View on ClinicalTrials.gov

Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 12, 2017

Primary Completion Date

January 30, 2018

Study Completion Date

January 30, 2018

Conditions
Healthy
Interventions
DRUG

Meditoxin

injection of MEDITOXIN into EDB muscle of one foot and BOTOX into the same muscle of contralateral foot in equal doses

DRUG

Botox

injection of MEDITOXIN into EDB muscle of one foot and BOTOX into the same muscle of contralateral foot in equal doses

Trial Locations (1)

Unknown

The Catholic University of Korea, St. Paul's Hospital, Seoul

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT03317717 - Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter